BIT225是Biotron有限公司正在开发的用于治疗HIV和丙型肝炎感染的实验性候选药物.通过阻断Vpu离子通道的活性,它扰乱了宿主单核细胞中HIV的组装；它的作用方式是HIV药物的首创.因为它的目标是单核细胞衍生的巨噬细胞的复制,它为治疗不受标准治疗影响的病毒库提供了希望.BIT225的活性是后病毒整合,对HIV酶逆转录酶和蛋白酶没有直接影响.由于Vpu离子通道活性高度保守,病毒不太可能通过产生Vpu离子无关病毒而变得具有抗性.此外,该药还被认为治疗12周后丙型肝炎治愈.
-
95% CAS No.:1013-83-8 -
SKU-Pack Size Availability Price（￥） Quantity R025048-1g In-Stock(Shanghai or CA Irwindale) R025048-5g In-Stock(Shanghai or CA Irwindale) R025048-10g In-Stock(Shanghai or CA Irwindale) R025048-25g In-Stock(Shanghai or CA Irwindale) R025048-100g In-Stock(Shanghai or CA Irwindale) R025048-250mg In-Stock(Shanghai or CA Irwindale) R025048-1g In-Stock(Shanghai or CA Irwindale) R025048-250mg In-Stock(Shanghai or CA Irwindale) R025048-5g In-Stock(Shanghai or CA Irwindale) R025048-1g In-Stock(Shanghai or CA Irwindale) R025048-250mg In-Stock(Shanghai or CA Irwindale) R025048-5g In-Stock(Shanghai or CA Irwindale) R025048-1g In-Stock(Shanghai or CA Irwindale) R025048-250mg In-Stock(Shanghai or CA Irwindale) R025048-5g In-Stock(Shanghai or CA Irwindale) R025048-1g In-Stock(Shanghai or CA Irwindale) R025048-250mg In-Stock(Shanghai or CA Irwindale) R025048-5g In-Stock(Shanghai or CA Irwindale) -
98% CAS No.:761446-44-0 -
SKU-Pack Size Availability Price（￥） Quantity R747606-1g In-Stock(Shanghai or CA Irwindale) R747606-5g In-Stock(Shanghai or CA Irwindale) R747606-10g In-Stock(Shanghai or CA Irwindale) R747606-25g In-Stock(Shanghai or CA Irwindale) R747606-100g In-Stock(Shanghai or CA Irwindale) R747606-500g In-Stock(Shanghai or CA Irwindale)